Antigen-presenting ILC3 regulate T cell-dependent IgA responses to colonic mucosal bacteria.


Journal

The Journal of experimental medicine
ISSN: 1540-9538
Titre abrégé: J Exp Med
Pays: United States
ID NLM: 2985109R

Informations de publication

Date de publication:
01 04 2019
Historique:
received: 10 05 2018
revised: 12 12 2018
accepted: 08 02 2019
pubmed: 1 3 2019
medline: 6 5 2020
entrez: 1 3 2019
Statut: ppublish

Résumé

Intestinal immune homeostasis is dependent upon tightly regulated and dynamic host interactions with the commensal microbiota. Immunoglobulin A (IgA) produced by mucosal B cells dictates the composition of commensal bacteria residing within the intestine. While emerging evidence suggests the majority of IgA is produced innately and may be polyreactive, mucosal-dwelling species can also elicit IgA via T cell-dependent mechanisms. However, the mechanisms that modulate the magnitude and quality of T cell-dependent IgA responses remain incompletely understood. Here we demonstrate that group 3 innate lymphoid cells (ILC3) regulate steady state interactions between T follicular helper cells (TfH) and B cells to limit mucosal IgA responses. ILC3 used conserved migratory cues to establish residence within the interfollicular regions of the intestinal draining lymph nodes, where they act to limit TfH responses and B cell class switching through antigen presentation. The absence of ILC3-intrinsic antigen presentation resulted in increased and selective IgA coating of bacteria residing within the colonic mucosa. Together these findings implicate lymph node resident, antigen-presenting ILC3 as a critical regulatory checkpoint in the generation of T cell-dependent colonic IgA and suggest ILC3 act to maintain tissue homeostasis and mutualism with the mucosal-dwelling commensal microbiota.

Identifiants

pubmed: 30814299
pii: jem.20180871
doi: 10.1084/jem.20180871
pmc: PMC6446868
doi:

Substances chimiques

Histocompatibility Antigens Class II 0
Immunoglobulin A 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

728-742

Subventions

Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/F019726/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 110199/Z/15/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L011840/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BBS/E/D/20002174
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom

Informations de copyright

© 2019 Melo-Gonzalez et al.

Références

J Exp Med. 2002 Aug 19;196(4):505-15
pubmed: 12186842
Immunity. 2002 Sep;17(3):363-73
pubmed: 12354388
J Exp Med. 2003 May 5;197(9):1199-204
pubmed: 12732661
J Exp Med. 2006 Oct 30;203(11):2485-94
pubmed: 17030948
J Exp Med. 2007 Apr 16;204(4):747-58
pubmed: 17420268
Nat Protoc. 2007;2(11):2692-703
pubmed: 18007604
Nature. 2010 Jan 28;463(7280):540-4
pubmed: 20023630
Annu Rev Immunol. 2010;28:243-73
pubmed: 20192805
PLoS Pathog. 2010 May 13;6(5):e1000902
pubmed: 20485566
Eur J Immunol. 2011 Jun;41(6):1563-72
pubmed: 21469096
Immunity. 2011 Jun 24;34(6):947-60
pubmed: 21636295
Immunity. 2011 Nov 23;35(5):671-80
pubmed: 22118524
Science. 2012 Jun 8;336(6086):1268-73
pubmed: 22674334
Immunity. 2012 Oct 19;37(4):601-10
pubmed: 23084357
Nature. 2012 Nov 1;491(7422):119-24
pubmed: 23128233
Nature. 2013 Jun 6;498(7452):113-7
pubmed: 23698371
Science. 2013 Dec 6;342(6163):1243-6
pubmed: 24311691
Nat Immunol. 2014 Apr;15(4):354-364
pubmed: 24562309
Curr Opin Immunol. 2014 Apr;27:75-82
pubmed: 24594491
Science. 2014 Mar 28;343(6178):1249288
pubmed: 24625929
Cell. 2014 Mar 27;157(1):121-41
pubmed: 24679531
Immunity. 2014 Aug 21;41(2):283-95
pubmed: 25088770
Cell. 2014 Aug 28;158(5):1000-1010
pubmed: 25171403
Nat Commun. 2015 Jan 09;6:5862
pubmed: 25575242
Methods Mol Biol. 2015;1291:151-60
pubmed: 25836309
Science. 2015 May 29;348(6238):1031-5
pubmed: 25908663
Cell Host Microbe. 2015 May 13;17(5):617-27
pubmed: 25936799
Trends Immunol. 2015 Aug;36(8):460-70
pubmed: 26169256
Immunity. 2015 Sep 15;43(3):541-53
pubmed: 26320660
Mucosal Immunol. 2016 Mar;9(2):468-78
pubmed: 26329428
Immunol Rev. 2016 Mar;270(1):20-31
pubmed: 26864102
Science. 2016 May 13;352(6287):aaf4822
pubmed: 27174992
Nat Immunol. 2016 Jun 21;17(7):765-74
pubmed: 27328006
Nature. 2016 Jul 06;535(7610):75-84
pubmed: 27383982
Immunol Cell Biol. 2017 Jan;95(1):33-41
pubmed: 27465674
Nat Immunol. 2016 Oct;17(10):1197-1205
pubmed: 27573866
Nat Commun. 2016 Sep 01;7:12651
pubmed: 27582256
Nat Immunol. 2016 Dec;17(12):1436-1446
pubmed: 27695002
Nat Rev Immunol. 2016 Dec;16(12):767-774
pubmed: 27818504
Immunology. 2017 Mar;150(3):265-275
pubmed: 27935637
J Virol. 2017 Apr 28;91(10):
pubmed: 28275192
Nature. 2017 Apr 27;544(7651):498-502
pubmed: 28405025
Sci Immunol. 2017 Jul 21;2(13):null
pubmed: 28733471
J Exp Med. 2017 Sep 4;214(9):2507-2521
pubmed: 28747424
Science. 2017 Oct 20;358(6361):
pubmed: 28971969
Cell Host Microbe. 2017 Dec 13;22(6):733-745.e5
pubmed: 29241040
Immunity. 2018 Jan 16;48(1):120-132.e8
pubmed: 29343433
Nature. 2018 Feb 15;554(7692):373-377
pubmed: 29414937
Science. 2018 May 18;360(6390):795-800
pubmed: 29724905
Immunity. 2018 May 15;48(5):1014-1028.e6
pubmed: 29752062
Immunity. 2018 Jun 19;48(6):1245-1257.e9
pubmed: 29858010
Immunity. 2018 Jun 19;48(6):1195-1207.e6
pubmed: 29907525
Cell Rep. 2018 Jun 26;23(13):3750-3758
pubmed: 29949760

Auteurs

Felipe Melo-Gonzalez (F)

Lydia Becker Institute of Immunology and Inflammation, University of Manchester, Manchester, UK.
Manchester Collaborative Centre for Inflammation Research, Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.

Hana Kammoun (H)

Center for Infectious Medicine, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.

Elza Evren (E)

Center for Infectious Medicine, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.

Emma E Dutton (EE)

Institute of Immunology and Immunotherapy (III), College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.

Markella Papadopoulou (M)

Lydia Becker Institute of Immunology and Inflammation, University of Manchester, Manchester, UK.
Manchester Collaborative Centre for Inflammation Research, Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.

Barry M Bradford (BM)

The Roslin Institute and Royal (Dick) School of Veterinary Sciences, University of Edinburgh, Easter Bush, UK.

Ceylan Tanes (C)

Division of Gastroenterology, Hepatology, and Nutrition, The Children's Hospital of Philadelphia, Philadelphia, PA.

Fahmina Fardus-Reid (F)

Division of Integrative Systems Medicine and Digestive Diseases, Imperial College London, South Kensington, UK.

Jonathan R Swann (JR)

Division of Integrative Systems Medicine and Digestive Diseases, Imperial College London, South Kensington, UK.

Kyle Bittinger (K)

Division of Gastroenterology, Hepatology, and Nutrition, The Children's Hospital of Philadelphia, Philadelphia, PA.

Neil A Mabbott (NA)

The Roslin Institute and Royal (Dick) School of Veterinary Sciences, University of Edinburgh, Easter Bush, UK.

Bruce A Vallance (BA)

Department of Pediatrics, British Columbia Children's Hospital, University of British Columbia, Vancouver, Canada.

Tim Willinger (T)

Center for Infectious Medicine, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.

David R Withers (DR)

Institute of Immunology and Immunotherapy (III), College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.

Matthew R Hepworth (MR)

Lydia Becker Institute of Immunology and Inflammation, University of Manchester, Manchester, UK matthew.hepworth@manchester.ac.uk.
Manchester Collaborative Centre for Inflammation Research, Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH